Gastro Division

End to End solution in G.I care

Fourrts Gastro division was formed in 2013. It was carved out from Premiere division the oldest division of Fourrts.

Launched in 4 Southern states with a field force of 100 Professional Service Representative Gastro division was later was expanded to all India in 2014.

Today, Fourrts Gastro division operates with 285 Professional Services Representatives and a total of 363 field force including line managers.

Fourrts Gastro division is ranked 5th in the Gastro Intestinal therapy Covered market and 29th overall in IPM in G.I. therapy market. Fourrts Gastro division’s Flagship brands Sucrafil & Sucrafil O ranked no. 1 in Sucralfate Therapy in India & across the world.

Purpose of the Division

According to WHO more than 470 million or 39% of Indians suffer from gastrointestinal problems varying from heartburn to constipation and diarrhea. The purpose of Fourrts gastro division is to bridge the therapy gaps in the management of Gastro-intestinal disorders by offering innovative path breaking brands.

Vision of the division

The vision of Fourrts gastro division is to become a leader in Gastro-intestinal therapy in India and the world by offering health care solutions for all gastrointestinal problems benefitting people across all age groups from Children to elderly covering every section of the society by offering innovative, quality products at affordable cost.

Mission of the division

The Mission of Fourrts Gastro division is to be No. 1 in Gastro Covered Market and reach among the top 10 in IPM in G.I. therapy market. To register Rupees 300 crores sales by 2020-21.

Fourrts Gastro division is the only one in the Indian market to offer end to end solutions in GI therapy offering products from Mouth Ulcers to Piles.

Our Therapy offering in Gastroenterology includes:

Luminal Gastroenterology: GERD, Reflux Esophagitis, Gastritis, Duodenal & gastric ulcers, Oral ulcers, Radiation Mucositis, Ulcerative colitis, Crohn’s disease, probiotic therapy for adults & children

Hepato-Pancreato-Biliary diseases: NAFLD, Alcoholic Liver Disease, Viral Hepatitis, Cholestatic Liver Diseases (Gall stones, Cholangitis & Primary Biliary Cirrhosis), Drug Induced Hepatitis, Pancreatic Insufficiency

Functional GI disorders: Functional Dyspepsia, IBS & Functional constipation

Colorectal diseases: Piles, Fissures, Solitary rectal ulcers & Radiation Proctitis

Sucrafil suspension Sucralfate USP 500 mg per 5 ml
Sucrafil O Gel Sucralfate USP 500 mg,  Oxetacaine BP 10 mg per 5 ml
Sucrafil DS suspension Sucralfate USP 500 mg,    Domperidone BP 5 mg Simethicone IP 25 mg
Sucrafil Enema Sucralfate USP 2gms rectal suspension
Tocofil Tocotrienol (50%)   200 mg
Udimarin Tab Ursodeoxycholic acid    IP     300mg in betacyclodextrin base
Udimarin Forte Ursodeoxycholic Acid I.P- 300mg, Silymarin – 140mg
PrePro Streptococcus Faecalis-15 Million, Clostridium Butyricum -15 Million, Bacillus Mesentericus-15 Million, Lactobacillus Acidophilus  with FOS 15 Million
PrePro IBS Lactobacillus acidophilus  700 Million cfu,  Lactobacillus rhamnosus  600 Million cfu, Lactobacillus Casei  600 Million cfu, Lactobacillus bulgaricus 400 Million cfu, Lactobacillus plantarum 600 Million cfu, Bifidobacterium breve  500 Million cfu, Bifidobacterium longum  500 Million cfu, Bifidobacterium infantis  500 Million cfu, Streptococcus thermophilus  600 Million  cfu, Melatonin 3 mg
PrePro Kid Lactobacillus Acidophilus 650 Millions, Lactobacilus rhamnosus   400 millions, Bifidobacterium Longum  100 Millions, Bifidobacterium infantis  100 Millions, Saccharomyces boulardii 50 million, Elemental Zinc 10 mg, Fructo oligo saccharide  100 mg
Lanfil Dx Dexlansoprazole IP 60 mg
Laxopeg Polyethylene glycol 3350 – 17gm
Laxopeg FC Polyethylene Glycol  3350  USP  17g
Laxopeg Kid Polyethylene glycol  3350  USPNF    8.5g
Laxopeg Jar 119/255g Polyethylene glycol 3350 USP 17gm
Laxopeg fiber Polyethylene Glycol 3350  17g, Methylcellulose 2g,
Oxerute CD Troxerutin  BP   500mg, Calcium Dobesilate monohydrate  IP equivalent to Lactulose 3.35 g, Calcium Dobestilate       500mg
Oxerute Cream Troxerutin 2% w/w, Calcium Dobesilate Monohydrate B.P. 0.25% w/w, Lignocaine Hydrochloride IP 3% w/w, Hydrocortisone Acetate IP 0.25% w/w,    Zinc 5% w/w, Phenylephine Hydrochloride IP 0.1% w/w
Quadrajel Chlorheidine Gluconate Solution     IP, equivalent to Chlorhexidine Gluconate    1% w/w, Metronidazole Benzoate 1% w/w , Lignocaine Hydrochlorede           IP    2%, in Mentholated gel base
  • Sucrafil O gel was awarded brand of the year by AIOCD AWACS in 2017
  • Sucrafil & Sucrafil O gel together are ranked no.1 in Sucralfate market
  • Sucrafil suspension is ranked among top 300 brands in Nepal
  • Sucrafil & Sucrafil O Gel is registered & market in 14 countries world wide
  • Laxopeg and its SKUs together are ranked no.1 in value in PEG 3350 market
  • Fourrts Gastro division was the first to introduce Pre & Probiotic & Zincbiotic concept in India

044-43441880 (Ext- 217)